Neuroscience
Discussions about Targretin (bexarotene):
From The Wall Street Journal:
Alzheimer's Families Clamor for Drug
By Shirley S. Wang
11 February 2012
Read the article
From the In The Pipeline blog:
Bexarotene for Alzheimer's
13 February 2012
Read the blog posting
- Alzheimer's Disease: Genomic Data
Press release from the NIH: NIH deposits first batch of genomic data for Alzheimer’s disease Researchers gain rapid access to first set of raw human genome sequence 02 December 2013 [snip] "Researchers can now freely access the first batch of genome...
- Alzheimer's Disease: A Wrap For Bap
Trials for Alzheimer’s Drug Halted After Poor Results By KATIE THOMAS The New York Times 06 August 2012 Read full article ---Corporate Press Release: Read the releaseCommentary from the In The Pipeline blog: In The PipelineCommentary from Pharmalot:...
- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...
- Neugrid
From Business Wire: neuGRID, the European Online Diagnosis Tool for Alzheimer’s, Goes Global with outGRID and the ITU 20 February 2012 "neuGRID, a cloud-computing infrastructure funded by the European Commission that stores and analyses a vast database...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
Neuroscience
Alzheimer Disease: Discussions about Bexarotene
Discussions about Targretin (bexarotene):
From The Wall Street Journal:
Alzheimer's Families Clamor for Drug
By Shirley S. Wang
11 February 2012
Read the article
From the In The Pipeline blog:
Bexarotene for Alzheimer's
13 February 2012
Read the blog posting
- Alzheimer's Disease: Genomic Data
Press release from the NIH: NIH deposits first batch of genomic data for Alzheimer’s disease Researchers gain rapid access to first set of raw human genome sequence 02 December 2013 [snip] "Researchers can now freely access the first batch of genome...
- Alzheimer's Disease: A Wrap For Bap
Trials for Alzheimer’s Drug Halted After Poor Results By KATIE THOMAS The New York Times 06 August 2012 Read full article ---Corporate Press Release: Read the releaseCommentary from the In The Pipeline blog: In The PipelineCommentary from Pharmalot:...
- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...
- Neugrid
From Business Wire: neuGRID, the European Online Diagnosis Tool for Alzheimer’s, Goes Global with outGRID and the ITU 20 February 2012 "neuGRID, a cloud-computing infrastructure funded by the European Commission that stores and analyses a vast database...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...